Japanese Encephalitis Vaccine
ID: IXType: Sources Sought
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFOFFICE OF THE ASSISTANT SECRETARY FOR ADMINISTRATION (ASA)PROGRAM SUPPORT CENTER ACQ MGMT SVCROCKVILLE, MD, 20857, USA

NAICS

Pharmaceutical and Medicine Manufacturing (3254)

PSC

DRUGS AND BIOLOGICALS (6505)

Set Aside

No Set aside used (NONE)

Original Source

https://sam.gov/workspace/contract/opp/66240b33a11e44059fb3aee7c8920fbf/view
Timeline
    Description

    The Department of Health and Human Services is seeking suppliers for the Japanese Encephalitis Vaccine, specifically the Ixiaro brand or an equivalent product. The procurement involves a requirement for 800 syringes of the vaccine, identified by NDC# 42515-0002-01 and NSN: 6505-01-607-7018, which is critical for immunization against Japanese Encephalitis, a serious viral infection. Interested vendors should note that the place of performance is Perry Point, Maryland, and they can reach out to Tim Bouchelle at Timothy.Bouchelle@hhs.gov or by phone at 443-947-6039 for further inquiries. This opportunity is categorized under the Pharmaceutical and Medicine Manufacturing industry, with no set-aside restrictions.

    Point(s) of Contact
    Tim Bouchelle
    (443) 947-6039
    (410) 642-3566
    Timothy.Bouchelle@hhs.gov
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    Japanese Encephalitis Vaccine
    Currently viewing
    Sources Sought
    Similar Opportunities
    65--TYPHOID VI POLYSACC
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA Troop Support), is seeking quotes for the procurement of Typhoid VI Polysaccharide vaccine, identified by NSN 6505013856328. The requirement includes the delivery of 5 units to the USS Emory S. Land AS 39 and 100 units to the USS McCampbell DDG 85, both due within 20 days after order. This vaccine is critical for maintaining the health and readiness of military personnel, particularly in environments where typhoid fever is a risk. Interested vendors, particularly those classified as Service-Disabled Veteran-Owned Small Businesses (SDVOSBC), must submit their quotes electronically, with further inquiries directed to the DLA at DibbsBSM@dla.mil.
    J&A Procurement of Smallpox (Mpox) Vaccine for the Strategic National Stockpile
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Office of Assistant Secretary for Preparedness and Response (BARDA), is seeking to procure additional doses of the JYNNEOS™ vaccine for the Strategic National Stockpile in response to the ongoing monkeypox outbreak. The procurement aims to rapidly secure 11 million doses of the vaccine by utilizing existing bulk drug substance and to enhance manufacturing capacity through technology transfer to contract manufacturing organizations. The JYNNEOS™ vaccine is critical as it is the only licensed vaccine for both smallpox and monkeypox, making it essential for public health preparedness. Interested parties can contact Yifan Yang at yifan.yang@hhs.gov, with the total estimated value of the contract modification being $992,400,000.
    Vaccines for Children (VFC) FY26
    Health And Human Services, Department Of
    The Centers for Disease Control and Prevention (CDC) is seeking manufacturers to provide pediatric vaccines under the Vaccines for Children (VFC) program through an Indefinite Delivery Indefinite Quantity (IDIQ) contract. This procurement aims to secure a wide range of vaccines, including DTaP, Hepatitis A and B, MMR, and Pneumococcal, for eligible children aged 18 and younger, ensuring that those who are Medicaid-eligible, uninsured, or American Indian/Alaska Native receive necessary immunizations. The contract period spans from April 1, 2026, to March 31, 2027, with a maximum combined value exceeding $13 billion, and interested parties must adhere to strict requirements regarding shelf life, packaging, and delivery timelines. For further inquiries, potential offerors can contact James Sprigler at zbs6@cdc.gov or Chad Turner at ukr9@cdc.gov.
    6505--Ustekinumab Pens/Syringes or Biosimilar
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Ustekinumab Pens/Syringes or Biosimilars, aimed at supplying various federal health entities including the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The contract will be awarded for an initial period of one year, with the possibility of four additional one-year option periods, ensuring a consistent supply of these critical pharmaceutical products through the VA and DoD Pharmaceutical Prime Vendor Programs. Offerors must provide drugs with unique National Drug Code (NDC) numbers and ensure that any biosimilar products meet FDA licensing requirements, as outlined in the FDA Purple Book. The solicitation is expected to be released around January 12, 2026, with a tentative closing date of January 27, 2026; interested parties should direct inquiries to Chris Carthron at Christopher.Carthron@va.gov or (708) 786-4980.
    National Immunization Survey - Flu Q2-Q4 2023 Bridge Contract
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking to continue the National Immunization Survey through a bridge contract for the second to fourth quarters of 2023. This contract, awarded to the National Opinion Research Center (NORC), aims to ensure the timely collection and analysis of immunization data, which is critical for public health decision-making and policy formulation. The justification for this contract was made under the authority of FAR 6.302-2 due to unusual and compelling urgency, and the associated Justification and Approval for Other Than Full and Open Competition (JOFOC) will be available for review for 30 days following the contract award. For further inquiries, interested parties may contact Joshua Houston at pkf5@cdc.gov.
    National Clinical Vaccination (NCV) Contract Extension
    Homeland Security, Department Of
    The Department of Homeland Security, specifically the Federal Emergency Management Agency (FEMA), is extending the National Clinical Vaccination (NCV) Contract to secure contractor-managed licensed medical professionals for COVID-19 vaccine administration. This extension aims to support federal assistance to state, local, tribal, and territorial partners in response to Major Disaster Declarations related to the COVID-19 pandemic, in accordance with various legislative acts including the Robert T. Stafford Act and the Public Health Service Act. The services are critical for ensuring effective vaccine distribution and administration during ongoing public health emergencies. Interested parties can reach out to Michael Bonds at michael.bonds@fema.dhs.gov or call 202-257-8893 for further details regarding this opportunity.
    6505--766-26-1-400-0207 -Charleston CMOP 2 Pharmaceuticals -(VA-26-00025368)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking to procure two specific pharmaceuticals, JASMIEL (J0040) 28-DAY TABLET and DROSPIRENONE 4MG (D1217), for the Consolidated Mail Outpatient Pharmacy (CMOP) in Ladson (Charleston). This procurement is critical as the products have been prescribed by VA physicians, and no substitutions are permitted due to the absence of alternative suppliers in the market. Vendors are required to submit a signed SF1449, a completed pricing schedule, a valid State Wholesale Distributor License, and a Buy American Act Certificate by January 5, 2026, at 3:00 PM CT, with deliveries staggered over a six-month period starting ten days after order receipt. Interested parties should direct their quotes to Kelley Cunningham at kelley.cunningham@va.gov.
    Animal Vaccines
    Agriculture, Department Of
    The Department of Agriculture, specifically the Agricultural Research Service (USDA ARS), is seeking quotations for the procurement of animal vaccines under solicitation number 1232SA26Q0014. The contractor will supply essential vaccines for research animals, including beef cattle, swine, and sheep, with specific requirements for products such as Guardian, Brute Pour On, and PregGuard Gold FP10, among others, all with expiration dates of January 1, 2027, or later. This procurement is critical for maintaining the health of research animals at the Roman L. Hruska U.S. Meat Animal Research Center in Clay Center, Nebraska, with a delivery deadline set for January 5, 2026. Interested vendors must acknowledge the amendment to the solicitation, submit their quotes by January 6, 2026, and direct any inquiries to Brian Brusky at brian.brusky@usda.gov or by phone at 608-215-2837.
    COVID 19 Tests
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Office of Assistant Secretary for Preparedness and Response, is seeking procurement for COVID-19 tests. The opportunity involves the acquisition of in vitro diagnostic substances, reagents, test kits, and sets, with a focus on ensuring compliance with the Trade Agreements Act (TAA). This procurement is critical for enhancing the nation's testing capabilities in response to the ongoing pandemic. Interested vendors can reach out to Junli Collins at junli.collins@hhs.gov or Judy Williams at judy.williams2@hhs.gov for further details, as outlined in the attached justification document.
    Lenalidomide/Revlimid - Brand Name or Equal
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to supply Lenalidomide/Revlimid medication, either brand name or equal, for the Edward Hines Jr. VA Hospital Pharmacy Service in Hines, Illinois. This procurement includes the delivery of various dosages of Lenalidomide capsules for a contract period from January 5, 2026, to January 4, 2027, and requires that the successful offeror be a pharmacy certified with the Lenalidomide Risk Evaluation and Mitigation Strategy (REMS) program. The medication is critical for treating certain conditions, and the procurement process will be based on the lowest price technically acceptable offers, with payment processing handled electronically through the Tungsten Network. Interested parties must submit their quotes via email to the primary contact, Arneil Genus, at arneil.genus@va.gov by the deadline of December 26, 2025, at 3 PM CST.